// App-Quantinova.ai

: Extended Half‐life Recombinant Factor IXFc Is Effective in Preventing Bleeding after Major and Minor Surgery in Severe Factor IX Deficiency

Researchers

Presenter

  • M. O'Donovan

Principal Investigators

  • K. Johnston

  • E. Singleton

  • S. Roche

  • M. Byrne

  • B. Kevane

  • K. Ryan

  • N. O'Connell

Medical Centers

  • National Coagulation Centre, St James's Hospital, Dublin, Ireland

  • University College Dublin, Dublin 4, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

Disease

  • Hemophilia

  • Tuberculosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved